申请人:Spangelo Bryan L.
公开号:US20130225546A1
公开(公告)日:2013-08-29
A method of reducing the in vivo viability of cancer cells selected from the group consisting of breast cancer cells, lung cancer cells, prostate cancer cells and melanoma cancer cells has steps of:
a) identifying a prospective patient having cancer cells selected from the group consisting of breast cancer cells, lung cancer cells, prostate cancer cells and melanoma cancer cells; and
b) administering a cisplatin derivative to the prospective patient so that the cisplatin derivative will contact the cancer cells;
wherein the cisplatin derivative is a 4,4′-bis[RO]-2,2′-bipyridine)PtCl
2
where, R is selected from the group consisting of —(CH
2
)
n
CH3 where n=2, 3, 4 or 5, and —(CH
2
)
n
[O(CH
2
)
m
]
y
O(CH
2
)
z
CH
3
where n=2, m=2, y=2, z=1. A novel synthetic process for the manufacture of these compounds (and their analogs) is also provided.
一种减少乳腺癌细胞、肺癌细胞、前列腺癌细胞和黑色素瘤癌细胞在体内存活能力的方法,包括以下步骤:a) 识别患有乳腺癌细胞、肺癌细胞、前列腺癌细胞和黑色素瘤癌细胞中的一种或多种的潜在患者;和b) 向潜在患者给予顺铂衍生物,使顺铂衍生物接触到癌细胞;其中,顺铂衍生物是4,4'-双[RO]-2,2'-联吡啶)PtCl2,其中,R选自—(CH2)nCH3(其中n=2、3、4或5)和—(CH2)n[O(CH2)m]yO(CH2)zCH3(其中n=2、m=2、y=2、z=1)的群体中。同时提供一种制造这些化合物(及其类似物)的新型合成方法。